Pila Pharma AB (publ) (STO:PILA)
2.295
+0.165 (7.75%)
Jan 21, 2026, 5:29 PM CET
Pila Pharma AB Revenue
Pila Pharma AB had revenue of 851.00K SEK in the half year ending June 30, 2025, a decrease of -22.42%. This brings the company's revenue in the last twelve months to 957.89K, down -8.69% year-over-year. In the year 2024, Pila Pharma AB had annual revenue of 789.89K, down -46.01%.
Revenue (ttm)
957.89K
Revenue Growth
-8.69%
P/S Ratio
93.58
Revenue / Employee
957.89K
Employees
1
Market Cap
89.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 789.89K | -673.13K | -46.01% |
| Dec 31, 2023 | 1.46M | -417.72K | -22.21% |
| Dec 31, 2022 | 1.88M | 1.16M | 161.49% |
| Dec 31, 2021 | 719.23K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |